In developing countries, medical diagnosis is expensive and time consuming. Hence, automatic diagnosis can be a good cheap alternative. This task can be performed with artificial intelligence tools such as deep Convolutional Neural Networks (CNNs). These tools can be used on medical images to speed up the diagnosis process and save the efforts of specialists. The deep CNNs allow direct learning from the medical images. However, the accessibility of classified data is still the largest challenge, particularly in the field of medical imaging. Transfer learning can deliver an effective and promising solution by transferring knowledge from universal object detection CNNs to medical image classification. However, because of the inhomogeneity and enormous overlap in intensity between medical images in terms of features in the diagnosis of Pneumonia and COVID-19, transfer learning is not usually a robust solution. Single-Image Super-Resolution (SISR) can facilitate learning to enhance computer vision functions, apart from enhancing perceptual image consistency. Consequently, it helps in showing the main features of images. Motivated by the challenging dilemma of Pneumonia and COVID-19 diagnosis, this paper introduces a hybrid CNN model, namely SIGTra, to generate super-resolution versions of X-ray and CT images. It depends on a Generative Adversarial Network (GAN) for the super-resolution reconstruction problem. Besides, Transfer learning with CNN (TCNN) is adopted for the classification of images. Three different categories of chest X-ray and CT images can be classified with the proposed model. A comparison study is presented between the proposed SIGTra model and the other related CNN models for COVID-19 detection in terms of precision, sensitivity, and accuracy.
infection was initially acknowledged as a global pandemic in Wuhan in China. World Health Organization (WHO) stated that the COVID-19 is an epidemic that causes a 3.4% death rate. Chest X-Ray (CXR) and Computerized Tomography (CT) screening of infected persons are essential in diagnosis applications. There are numerous ways to identify positive COVID-19 cases. One of the fundamental ways is radiology imaging through CXR, or CT images. The comparison of CT and CXR scans revealed that CT scans are more effective in the diagnosis process due to their high quality. Hence, automated classification techniques are required to facilitate the diagnosis process. Deep Learning (DL) is an effective tool that can be utilized for detection and classification this type of medical images. The deep Convolutional Neural Networks (CNNs) can learn and extract essential features from different medical image datasets. In this paper, a CNN architecture for automated COVID-19 detection from CXR and CT images is offered. Three activation functions as well as three optimizers are tested and compared for this task. The proposed architecture is built from scratch and the COVID-19 image datasets are directly fed to train it. The performance is tested and investigated on the CT and CXR datasets. Three activation functions: Tanh, Sigmoid, and ReLU are compared using a constant learning rate and different batch sizes. Different optimizers are studied with different batch sizes and a constant learning rate. Finally, a comparison between different combinations of activation functions and optimizers is presented, and the optimal configuration is determined. Hence, the main objective is to improve the detection accuracy of COVID-19 from CXR and CT images using DL by employing CNNs to classify medical COVID-19 images in an early stage. The proposed model achieves a classification accuracy of 91.67% on CXR image dataset, and a classification accuracy of 100% on CT dataset with training times of 58 min and 46 min on CXR and CT datasets, respectively. The best
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.